The global market for Blood Cell Separation was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Cell Separation, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blood Cell Separation by region & country, by Type, and by Application.
The Blood Cell Separation market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Cell Separation.
麻豆原创 Segmentation
By Company
Thermo Fisher Scientific Inc.
Beckman Coulter, Inc.
GENERAL ELECTRIC COMPANY
Merck KGaA
STEMCELL Technologies Inc.
Bio-Rad Laboratories, Inc.
TERUMO BCT, INC.
Segment by Type:
Human Cells
Animal Cells
Segment by Application
Biomolecule Isolation
Cancer Research
Stem Cell Research
In-vitro Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blood Cell Separation manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Blood Cell Separation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Blood Cell Separation in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Blood Cell Separation Product Introduction
1.2 Global Blood Cell Separation 麻豆原创 Size Forecast
1.3 Blood Cell Separation 麻豆原创 Trends & Drivers
1.3.1 Blood Cell Separation Industry Trends
1.3.2 Blood Cell Separation 麻豆原创 Drivers & Opportunity
1.3.3 Blood Cell Separation 麻豆原创 Challenges
1.3.4 Blood Cell Separation 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Blood Cell Separation Players Revenue Ranking (2023)
2.2 Global Blood Cell Separation Revenue by Company (2019-2024)
2.3 Key Companies Blood Cell Separation Manufacturing Base Distribution and Headquarters
2.4 Key Companies Blood Cell Separation Product Offered
2.5 Key Companies Time to Begin Mass Production of Blood Cell Separation
2.6 Blood Cell Separation 麻豆原创 Competitive Analysis
2.6.1 Blood Cell Separation 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Blood Cell Separation Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Cell Separation as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Human Cells
3.1.2 Animal Cells
3.2 Global Blood Cell Separation Sales Value by Type
3.2.1 Global Blood Cell Separation Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Blood Cell Separation Sales Value, by Type (2019-2030)
3.2.3 Global Blood Cell Separation Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biomolecule Isolation
4.1.2 Cancer Research
4.1.3 Stem Cell Research
4.1.4 In-vitro Diagnostics
4.2 Global Blood Cell Separation Sales Value by Application
4.2.1 Global Blood Cell Separation Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Blood Cell Separation Sales Value, by Application (2019-2030)
4.2.3 Global Blood Cell Separation Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Blood Cell Separation Sales Value by Region
5.1.1 Global Blood Cell Separation Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Blood Cell Separation Sales Value by Region (2019-2024)
5.1.3 Global Blood Cell Separation Sales Value by Region (2025-2030)
5.1.4 Global Blood Cell Separation Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Blood Cell Separation Sales Value, 2019-2030
5.2.2 North America Blood Cell Separation Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Blood Cell Separation Sales Value, 2019-2030
5.3.2 Europe Blood Cell Separation Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Blood Cell Separation Sales Value, 2019-2030
5.4.2 Asia Pacific Blood Cell Separation Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Blood Cell Separation Sales Value, 2019-2030
5.5.2 South America Blood Cell Separation Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Blood Cell Separation Sales Value, 2019-2030
5.6.2 Middle East & Africa Blood Cell Separation Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Blood Cell Separation Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Blood Cell Separation Sales Value
6.3 United States
6.3.1 United States Blood Cell Separation Sales Value, 2019-2030
6.3.2 United States Blood Cell Separation Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Blood Cell Separation Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Blood Cell Separation Sales Value, 2019-2030
6.4.2 Europe Blood Cell Separation Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Blood Cell Separation Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Blood Cell Separation Sales Value, 2019-2030
6.5.2 China Blood Cell Separation Sales Value by Type (%), 2023 VS 2030
6.5.3 China Blood Cell Separation Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Blood Cell Separation Sales Value, 2019-2030
6.6.2 Japan Blood Cell Separation Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Blood Cell Separation Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Blood Cell Separation Sales Value, 2019-2030
6.7.2 South Korea Blood Cell Separation Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Blood Cell Separation Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Blood Cell Separation Sales Value, 2019-2030
6.8.2 Southeast Asia Blood Cell Separation Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Blood Cell Separation Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Blood Cell Separation Sales Value, 2019-2030
6.9.2 India Blood Cell Separation Sales Value by Type (%), 2023 VS 2030
6.9.3 India Blood Cell Separation Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific Inc.
7.1.1 Thermo Fisher Scientific Inc. Profile
7.1.2 Thermo Fisher Scientific Inc. Main Business
7.1.3 Thermo Fisher Scientific Inc. Blood Cell Separation Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Inc. Blood Cell Separation Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Inc. Recent Developments
7.2 Beckman Coulter, Inc.
7.2.1 Beckman Coulter, Inc. Profile
7.2.2 Beckman Coulter, Inc. Main Business
7.2.3 Beckman Coulter, Inc. Blood Cell Separation Products, Services and Solutions
7.2.4 Beckman Coulter, Inc. Blood Cell Separation Revenue (US$ Million) & (2019-2024)
7.2.5 Beckman Coulter, Inc. Recent Developments
7.3 GENERAL ELECTRIC COMPANY
7.3.1 GENERAL ELECTRIC COMPANY Profile
7.3.2 GENERAL ELECTRIC COMPANY Main Business
7.3.3 GENERAL ELECTRIC COMPANY Blood Cell Separation Products, Services and Solutions
7.3.4 GENERAL ELECTRIC COMPANY Blood Cell Separation Revenue (US$ Million) & (2019-2024)
7.3.5 Merck KGaA Recent Developments
7.4 Merck KGaA
7.4.1 Merck KGaA Profile
7.4.2 Merck KGaA Main Business
7.4.3 Merck KGaA Blood Cell Separation Products, Services and Solutions
7.4.4 Merck KGaA Blood Cell Separation Revenue (US$ Million) & (2019-2024)
7.4.5 Merck KGaA Recent Developments
7.5 STEMCELL Technologies Inc.
7.5.1 STEMCELL Technologies Inc. Profile
7.5.2 STEMCELL Technologies Inc. Main Business
7.5.3 STEMCELL Technologies Inc. Blood Cell Separation Products, Services and Solutions
7.5.4 STEMCELL Technologies Inc. Blood Cell Separation Revenue (US$ Million) & (2019-2024)
7.5.5 STEMCELL Technologies Inc. Recent Developments
7.6 Bio-Rad Laboratories, Inc.
7.6.1 Bio-Rad Laboratories, Inc. Profile
7.6.2 Bio-Rad Laboratories, Inc. Main Business
7.6.3 Bio-Rad Laboratories, Inc. Blood Cell Separation Products, Services and Solutions
7.6.4 Bio-Rad Laboratories, Inc. Blood Cell Separation Revenue (US$ Million) & (2019-2024)
7.6.5 Bio-Rad Laboratories, Inc. Recent Developments
7.7 TERUMO BCT, INC.
7.7.1 TERUMO BCT, INC. Profile
7.7.2 TERUMO BCT, INC. Main Business
7.7.3 TERUMO BCT, INC. Blood Cell Separation Products, Services and Solutions
7.7.4 TERUMO BCT, INC. Blood Cell Separation Revenue (US$ Million) & (2019-2024)
7.7.5 TERUMO BCT, INC. Recent Developments
8 Industry Chain Analysis
8.1 Blood Cell Separation Industrial Chain
8.2 Blood Cell Separation Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Blood Cell Separation Sales Model
8.5.2 Sales Channel
8.5.3 Blood Cell Separation Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Thermo Fisher Scientific Inc.
Beckman Coulter, Inc.
GENERAL ELECTRIC COMPANY
Merck KGaA
STEMCELL Technologies Inc.
Bio-Rad Laboratories, Inc.
TERUMO BCT, INC.
听
听
*If Applicable.